Research with Gedeon Richter Unveils Key Brain Effects of Antipsychotic Drugs A groundbreaking study by Professor E. Sylvester Vizi, former President of the Hungarian Academy of Sciences, former Head of the... 2024.11.18.
Richter Sees Robust Sales Fueled by Pharma Revenue Gedeon Richter’s headquarters in Budapest. Consolidated sales of Gedeon Richter amounted to HUF 636.4 billion (EUR 1.5 billion) in the... 2024.11.13.
Richter Announces Collaboration with U.S. Pharmaceutical Company Richter Gedeon’s headquarters in Budapest Budapest-based pharmaceutical giant Richter announced a new research and development collaboration in the field of... 2024.10.25.
New Product to Bring in EUR 100 Million a Year for Pharmaceutical Giant Richter The acquisition of the European commercial rights to Stelara could boost the Hungarian pharmaceutical company Richter's sales by EUR 100... 2024.10.11.
Richter’s Female Health Product to Be Marketed in Japan Gedeon Richter Plc.'s partner, Fuji Pharma Co., Ltd. has received marketing approval for the combination tablet Alyssa, developed in Japan.... 2024.09.25.
Surprising Target Price Set for Pharmaceutical Giant Richter’s Shares In a few years, Gedeon Richter Plc's revenue could rise by 50 percent, according to MBH Bank, that started tracking... 2024.09.11.
Pharmaceutical Company Gedeon Richter Reports Robust First Half of 2024 In the first half of 2024, Gedeon Richter reported consolidated revenue of HUF 419.69B (EUR 1.05B), a 1.5 percent increase... 2024.08.06.
Pharmaceutical Giant Richter Acquires Belgium-based Biotech Company The pharmaceutical company's newly inaugurated headquarters in Budapest Gedeon Richter Plc. announced yesterday that it has acquired BCI Pharma, a... 2024.06.26.
Pharmaceutical Giant Gedeon Richter Unveils its New Headquarters in Budapest The new headquarters of the Hungarian pharmaceutical firm Gedeon Richter in the 10th district of the capital was inaugurated on... 2024.06.14.
Pharmaceutical Giant Gedeon Richter Elects New Chairman Effective March 1, Erik Bogsch has resigned from his position as Chairman of the Board of Directors of Gedeon Richter... 2024.02.26.
Leading Hungarian Pharmaceutical Company to Pay Billions in Windfall Tax According to the government decree on extra profit taxes, Richter Gedeon Nyrt. is expected to pay a windfall tax on... 2022.12.28.
Hungarian Pharmaceutical Success in the United States Good news for the Hungarian pharmaceutical company Richter and all its shareholders: the U.S. Food and Drug Administration (FDA) has... 2022.12.19.
Foundation Stone Laid for Richter’s New Head Office Building The foundation stone of Richter Gedeon Nyrt.'s new head office building was laid on Tuesday in Budapest. The 17,400 square... 2022.03.23.
Press Roundup: First Comments on the Russian Invasion of Ukraine A liberal correspondent believes that Russia intends to topple the Kiev government but will not attempt to keep Ukraine under... 2022.02.25.
Hungarian-Developed Coronavirus Medicine’s Clinical Trials may Begin in 2023 After animal experiments and toxicological tests, clinical trials of the Hungarian coronavirus medicine could start in early 2023, according to... 2021.10.25.
